Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,426 | 110,181 | 7,416 | 10,181 | 6,322 |
| Receivables | 33 | 35 | 136 | 1,538 | 44 |
| Inventories | N/A | N/A | N/A | 0 | 18 |
| TOTAL | $95,894 | $111,213 | $8,395 | $12,659 | $7,519 |
| Non-Current Assets | |||||
| PPE Net | 1,780 | 1,882 | 1,965 | 2,071 | 2,176 |
| Intangibles | 10,502 | 10,502 | 10,502 | 14,409 | 14,409 |
| Other Non-Current Assets | 131 | 131 | 131 | 131 | 131 |
| TOTAL | $12,413 | $12,515 | $12,598 | $16,611 | $16,716 |
| Total Assets | $108,307 | $123,728 | $20,993 | $29,270 | $24,235 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 654 | 916 | 446 | 789 | 751 |
| Accrued Expenses | 7,888 | 7,383 | 4,172 | 5,216 | 7,588 |
| Other current liabilities | 87,855 | 207,401 | N/A | N/A | N/A |
| TOTAL | $96,397 | $215,700 | $4,618 | $6,005 | $22,454 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,893 | 8,951 | 8,916 | 8,406 | 8,594 |
| TOTAL | $14,061 | $9,113 | $9,071 | $8,570 | $8,750 |
| Total Liabilities | $110,458 | $224,813 | $13,689 | $14,575 | $31,204 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,034 | 1,034 | 1,034 | 808 | 85 |
| Common Shares | 1 | 1 | 1 | 192 | 14 |
| Retained earnings | -357,961 | -456,424 | -335,134 | -326,966 | -321,738 |
| TOTAL | $-2,151 | $-101,085 | $7,304 | $14,695 | $-6,969 |
| Total Liabilities And Equity | $108,307 | $123,728 | $20,993 | $29,270 | $24,235 |